Articular reparator- Chondroprotector

At the beginning of osteoarthritis of the joints patients are characterized by the loss of proteoglycan molecules in articular cartilage. These biochemical changes of cartilage in joints affected by osteoarthritis are not only given by the decrease of proteoglycan, but also hyaluronic acid. Sodium hyaluronate (hyaluronic acid, sodium salt) is a natural polymer belonging to the class of glycosaminoglycans (acid mucopolysaccharides). It is, therefore, a vital component of synovial fluid that is characterized by viscoelasticity, hygroscopicity and lubricating properties, qualities that protect the joints from pressure and friction which are subject to joint surfaces, which are generated by movement. The quality and characteristics of synovial fluid is directly related to the animal’s joints health. The therapeutic outcome with this product is directly related to the molecular weight of the same being it for Chinfield sodium hyaluronate an MW of 1,800,000 Daltons.

For the treatment of joint dysfunction due to non-infectious synovitis associated with osteoarthritis. In tendovaginitis, post-joint surgery or tendineae, intra-articular post-lavage and support in articular fractures repair.

Sport Equine

Adult Equines:
2 ml intra-articular in small or medium size articulations (interphalangeal joint, carpal, tarsal-metatarsal joints, etc.).
4 ml intra-articular in large size articulations (talar warm, femoral-tibial-patellar, etc.).
Vía intra-articular with strict aseptic and antiseptic measures.
In case it is necessary repeat administration, allow 7 days between applications in the same articulation.
It is recommended to not exceed three (3) applications in the same articulation.

Local: Inflammation of the articulation that will remit in 24 to 48 hours.
General: there are not described in the bibliography.

Given this product is of intra-articular use, its implementation will be done under strict aseptic and antiseptic conditions.
Avoid using local antiseptics such as chlorhexidine and quaternary ammonium salts, including benzalkonium chloride, as they may cause the precipitation of sodium hyaluronate.
Do not apply in IV way.
The administration of this product requires extreme attention in the following cases:
This product may aggravate local inflammation in animals with arthritis enrolled with severe inflammation of the joint. Administration should be postponed until the local symptom is treated and goes away.
Local pain due to intra-articular administration of this product is rare, but if the pain appeared after the application, you must try to keep the animal at rest for a short time. The international literature indicates that up to 22% of applications can cause inflammation of varying intensity in the area.
In the necessity of repeating the administration of the product allow 7 days to pass between applications in the same joint.
Cancel treatment if there is not a significant improvement of the symptoms after the third application.
Should be applied in joints with hydrarthrosis, drain excess synovial fluid prior to application.
Should have been kept refrigerated, not to apply cold. Should be allowed to increase its temperature before administration.

Glass vial x 2ml with 20 mg of Sodium Hyaluronate

Sodium Hyaluronate 20 mg
Formulation Agent c.s.p. 2 ml